| TTM
|
7/31/2026
|
7/31/2025
|
7/31/2024
|
7/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
21,448,000 | 21,448,000 | 18,831,000 | 16,285,000 | 14,368,000 |
| Cost of Revenue
|
-4,253,000 | -4,253,000 | -3,848,000 | -3,465,000 | -3,143,000 |
|
Gross Profit
|
17,195,000 | 17,195,000 | 14,983,000 | 12,820,000 | 11,225,000 |
| Selling, General and Administrative Expenses
|
-7,157,000 | -7,157,000 | -6,636,000 | -5,730,000 | -5,062,000 |
|
Research and Development Expenses
|
-3,376,000 | -3,376,000 | -2,928,000 | -2,754,000 | -2,539,000 |
| Depreciation, Amortization and Depletion
|
-485,000 | -485,000 | -481,000 | -483,000 | -483,000 |
|
Operating Income/Expenses
|
-11,018,000 | -11,018,000 | -10,045,000 | -8,967,000 | -8,084,000 |
|
Total Operating Profit/Loss
|
6,177,000 | 6,177,000 | 4,938,000 | 3,853,000 | 3,141,000 |
| Total Net Finance Income/Expense
|
-76,000 | -76,000 | -72,000 | -95,000 | -142,000 |
| Irregular Income/Expenses
|
-293,000 | -293,000 | -15,000 | -223,000 | 0 |
|
Other Income/Expense, Non-Operating
|
209,000 | 209,000 | -17,000 | 15,000 | -10,000 |
|
Non-Operating Income/Expenses, Total
|
-160,000 | -160,000 | -104,000 | -303,000 | -152,000 |
|
Pretax Income
|
6,017,000 | 6,017,000 | 4,834,000 | 3,550,000 | 2,989,000 |
|
Provision for Income Tax
|
-1,451,000 | -1,451,000 | -965,000 | -587,000 | -605,000 |
|
Net Income from Continuing Operations
|
4,566,000 | 4,566,000 | 3,869,000 | 2,963,000 | 2,384,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
4,566,000 | 4,566,000 | 3,869,000 | 2,963,000 | 2,384,000 |
|
Net Income after Non-Controlling/Minority Interests
|
4,566,000 | 4,566,000 | 3,869,000 | 2,963,000 | 2,384,000 |
|
Net Income Available to Common Stockholders
|
4,566,000 | 4,566,000 | 3,869,000 | 2,963,000 | 2,384,000 |
|
Diluted Net Income Available to Common Stockholders
|
4,566,000 | 4,566,000 | 3,869,000 | 2,963,000 | 2,384,000 |
|
Common Dividend per Share
|
4.80 | 4.80 | 4.16 | 3.60 | 3.12 |
| Basic EPS
|
16.53 | 16.53 | 13.82 | 10.58 | 8.49 |
| Diluted EPS
|
16.46 | 16.46 | 13.67 | 10.43 | 8.42 |
|
Basic Weighted Average Shares Outstanding
|
276,000 | 276,000 | 280,000 | 280,000 | 281,000 |
|
Diluted Weighted Average Shares Outstanding
|
277,000 | 277,000 | 283,000 | 284,000 | 283,000 |
|
Reported Normalized Basic EPS
|
-- | -- | -- | -- | 14.40 |
|
Reported Normalized Diluted EPS
|
24.27 | 24.27 | 20.15 | 16.94 | 14.40 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
6,093,000 | 6,093,000 | 4,906,000 | 3,645,000 | 3,131,000 |
|
EBITDA
|
6,939,000 | 6,939,000 | 5,715,000 | 4,434,000 | 3,937,000 |
|
Normalized EBITDA
|
9,288,000 | 9,288,000 | 7,698,000 | 6,597,000 | 5,649,000 |
7/31/2023 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade